| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Bacteriology and Immunology (M.L., A.R., M.H., O.R.) and Molecular/Cancer Biology Laboratory (K.P.), Haartman Institute, and the Departments of Clinical Chemistry and Obstetrics and Gynecology (A.R., K.N.), University of Helsinki, Helsinki, Finland
Address all correspondence and requests for reprints to: Dr. Mika Laitinen, Department of Bacteriology and Immunology, Haartman Institute, P.O. Box 21, University of Helsinki, FIN-00014 Helsinki, Finland. E-mail: mplaitin{at}cc.helsinki.fi
The development of ovarian follicles and subsequent corpus luteum formation is accompanied by very active angiogenesis. Ovarian granulosa cells produce vascular endothelial growth factor (VEGF), which is a potent endothelial cell mitogen and an angiogenic agent. The complementary DNAs of two other factors structurally related to VEGF, namely VEGF-B and VEGF-C, were recently cloned, but little is known of their regulation in the ovary. We first studied the expression of the messenger RNAs (mRNAs) of the three VEGF isotypes in freshly isolated human granulosa-luteal (GL) cells obtained at oocyte retrieval for in vitro fertilization. The hormonal regulation of these mRNAs was subsequently studied in primary cultures of human GL cells. Analysis of cultured GL cell RNA by reverse transcription-PCR revealed that these cells express the alternatively spliced transcripts representing 121-, 145-, and 165-amino acid VEGF isoforms. Northern blot hybridization analyses indicated that transcripts of 4.5 and 3.7 kilobases for VEGF, and 1.4 and 2.4 kilobases for VEGF-B and VEGF-C, respectively, are expressed in human GL cells. The basal VEGF mRNA levels declined steadily, whereas VEGF-B mRNA levels were rather invariant over a 10-day culture period of GL cells. In contrast, VEGF-C mRNA levels increased toward the end of culture. For studying the hormonal regulation of VEGF isotype mRNAs, GL cells were treated with hCG, recombinant human FSH, PGE2, as well as 8-bromo-cAMP and 12-O-tetradecanoylphorbol 13-acetate, which activate protein kinase A- and protein kinase C-dependent signaling pathways, respectively. All test agents stimulated the expression of VEGF mRNA levels in a concentration-dependent manner. Time-course studies indicated that all treatments induced VEGF mRNA levels as early as incubation for 2 h, and the effect was sustained up to 48 h. VEGF-B mRNA levels were not regulated by any of the test agents. However, we found that hCG and 8-bromo-cAMP decreased VEGF-C mRNA levels with a maximal response observed at 24 and 48 h after cellular treatment. We conclude that the mRNAs of VEGF, VEGF-B, and VEGF-C are expressed in human GL cells and that their mRNA steady state levels are regulated in cultured human GL cells in an isotype-specific manner. The differential regulation of VEGF, VEGF-B, and VEGF-C in human GL cells suggests that distinct VEGF isotypes may play different roles during the vascularization of the human ovarian follicle and corpus luteum.
This article has been cited by other articles:
![]() |
S. van den Driesche, M. Myers, E. Gay, K. J. Thong, and W. C. Duncan HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum Mol. Hum. Reprod., August 1, 2008; 14(8): 455 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tropea, F. Miceli, F. Minici, F. Tiberi, M. Orlando, M. F. Gangale, F. Romani, S. Catino, S. Mancuso, P. Navarra, et al. Regulation of Vascular Endothelial Growth Factor Synthesis and Release by Human Luteal Cells in Vitro J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2303 - 2309. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B Carlsson, M. P E Laitinen, J. E Scott, H. Louhio, L. Velentzis, T. Tuuri, J. Aaltonen, O. Ritvos, R. M L Winston, and O. Hovatta Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture. Reproduction, April 1, 2006; 131(4): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cherradi, C. Lejczak, A. Desroches-Castan, and J.-J. Feige Antagonistic Functions of Tetradecanoyl Phorbol Acetate-Inducible-Sequence 11b and HuR in the Hormonal Regulation of Vascular Endothelial Growth Factor Messenger Ribonucleic Acid Stability by Adrenocorticotropin Mol. Endocrinol., April 1, 2006; 20(4): 916 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tesone, R. L. Stouffer, S. M. Borman, J. D. Hennebold, and T. A. Molskness Vascular Endothelial Growth Factor (VEGF) Production by the Monkey Corpus Luteum During the Menstrual Cycle: Isoform-Selective Messenger RNA Expression In Vivo and Hypoxia-Regulated Protein Secretion In Vitro Biol Reprod, November 1, 2005; 73(5): 927 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Gruemmer, L Klein-Hitpass, and J Neulen Regulation of gene expression in endothelial cells: the role of human follicular fluid J. Mol. Endocrinol., February 1, 2005; 34(1): 37 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Fraser, J. Bell, H. Wilson, P. D. Taylor, K. Morgan, R. A. Anderson, and W. C. Duncan Localization and Quantification of Cyclic Changes in the Expression of Endocrine Gland Vascular Endothelial Growth Factor in the Human Corpus Luteum J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 427 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Sakurai, K Tamura, and H Kogo Vascular endothelial growth factor increases messenger RNAs encoding cyclooxygenase-II and membrane-associated prostaglandin E synthase in rat luteal cells J. Endocrinol., December 1, 2004; 183(3): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn Vascular Endothelial Growth Factor and Angiogenesis Pharmacol. Rev., December 1, 2004; 56(4): 549 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Gomez, I Lima, C Simon, and A Pellicer Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats Reproduction, April 1, 2004; 127(4): 483 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Abdel-Majid and J. S. Marshall Prostaglandin E2 Induces Degranulation-Independent Production of Vascular Endothelial Growth Factor by Human Mast Cells J. Immunol., January 15, 2004; 172(2): 1227 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. K. Anand, H.-J. Paust, K. Altenpohl, and A. K. Mukhopadhyay Regulation of Vascular Endothelial Growth Factor Production by Leydig Cells In Vitro: The Role of Protein Kinase A and Mitogen-Activated Protein Kinase Cascade Biol Reprod, May 1, 2003; 68(5): 1663 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.C. Martinez-Chequer, R.L. Stouffer, T.M. Hazzard, P.E. Patton, and T.A. Molskness Insulin-Like Growth Factors-1 and -2, but not Hypoxia, Synergize with Gonadotropin Hormone to Promote Vascular Endothelial Growth Factor-A Secretion by Monkey Granulosa Cells from Preovulatory Follicles Biol Reprod, April 1, 2003; 68(4): 1112 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimizu, J.-Y. Jiang, H. Sasada, and E. Sato Changes of Messenger RNA Expression of Angiogenic Factors and Related Receptors During Follicular Development in Gilts Biol Reprod, December 1, 2002; 67(6): 1846 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Luborsky, P. Thiruppathi, B. Rivnay, R. Roussev, C. Coulam, and E. Radwanska Evidence for different aetiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles or presence of ovarian autoantibodies Hum. Reprod., October 1, 2002; 17(10): 2641 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stimpfl, D. Tong, B. Fasching, E. Schuster, A. Obermair, S. Leodolter, and R. Zeillinger Vascular Endothelial Growth Factor Splice Variants and Their Prognostic Value in Breast and Ovarian Cancer Clin. Cancer Res., July 1, 2002; 8(7): 2253 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Redmer, V. Doraiswamy, B. J. Bortnem, K. Fisher, A. Jablonka-Shariff, A. T. Grazul-Bilska, and L. P. Reynolds Evidence for a Role of Capillary Pericytes in Vascular Growth of the Developing Ovine Corpus Luteum Biol Reprod, September 1, 2001; 65(3): 879 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neulen, D. Wenzel, C. Hornig, E. Wunsch, U. Weissenborn, K. Grunwald, R. Buttner, and H. Weich Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols Hum. Reprod., April 1, 2001; 16(4): 621 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Gunningham, M. J. Currie, C. Han, B. A. Robinson, P. A. E. Scott, A. L. Harris, and S. B. Fox The Short Form of the Alternatively Spliced flt-4 but not Its Ligand Vascular Endothelial Growth Factor C Is Related to Lymph Node Metastasis in Human Breast Cancers Clin. Cancer Res., November 1, 2000; 6(11): 4278 - 4286. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sugino, S. Kashida, S. Takiguchi, A. Karube, and H. Kato Expression of Vascular Endothelial Growth Factor and Its Receptors in the Human Corpus Luteum during the Menstrual Cycle and in Early Pregnancy J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3919 - 3924. [Abstract] [Full Text] |
||||
![]() |
B. Berisha, D. Schams, M. Kosmann, W. Amselgruber, and R. Einspanier Expression and Tissue Concentration of Vascular Endothelial Growth Factor, Its Receptors, and Localization in the Bovine Corpus Luteum During Estrous Cycle and Pregnancy Biol Reprod, October 1, 2000; 63(4): 1106 - 1114. [Abstract] [Full Text] |
||||
![]() |
N. A. Cataldo, D. A. Dumesic, P. C. Goldsmith, and R. B. Jaffe Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis Hum. Reprod., September 1, 2000; 15(9): 1889 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Barboni, M. Turriani, G. Galeati, M. Spinaci, M. L. Bacci, M. Forni, and M. Mattioli Vascular Endothelial Growth Factor Production in Growing Pig Antral Follicles Biol Reprod, September 1, 2000; 63(3): 858 - 864. [Abstract] [Full Text] |
||||
![]() |
J. M. Fredriksson, J. M. Lindquist, G. E. Bronnikov, and J. Nedergaard Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression in Brown Adipocytes through a beta -Adrenoreceptor/cAMP/Protein Kinase A Pathway Involving Src but Independently of Erk1/2 J. Biol. Chem., April 28, 2000; 275(18): 13802 - 13811. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levitas, D. Chamoun, L. C. Udoff, M. Ando, C. E. Resnick, and E. Y. Adashi Periovulatory and Interleukin-1{beta}-Dependent Up-Regulation of Intraovarian Vascular Endothelial Growth Factor (VEGF) in the Rat: Potential Role for VEGF in the Promotion of Periovulatory Angiogenesis and Vascular Permeability Reproductive Sciences, January 1, 2000; 7(1): 51 - 60. [Abstract] [PDF] |
||||
![]() |
J. Aaltonen, M. P. Laitinen, K. Vuojolainen, R. Jaatinen, N. Horelli-Kuitunen, L. Seppä, H. Louhio, T. Tuuri, J. Sjöberg, R. Bützow, et al. Human Growth Differentiation Factor 9 (GDF-9) and Its Novel Homolog GDF-9B Are Expressed in Oocytes during Early Folliculogenesis J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2744 - 2750. [Abstract] [Full Text] |
||||
![]() |
F. Gaytán, C. Morales, L. García-Pardo, C. Reymundo, C. Bellido, and J.E. Sánchez-Criado A Quantitative Study of Changes in the Human Corpus Luteum Microvasculature during the Menstrual Cycle Biol Reprod, April 1, 1999; 60(4): 914 - 919. [Abstract] [Full Text] |
||||
![]() |
R. F. Nicosia What Is the Role of Vascular Endothelial Growth Factor-Related Molecules in Tumor Angiogenesis? Am. J. Pathol., July 1, 1998; 153(1): 11 - 16. [Full Text] [PDF] |
||||
![]() |
M. Stoner, F. Wang, M. Wormke, T. Nguyen, I. Samudio, C. Vyhlidal, D. Marme, G. Finkenzeller, and S. Safe Inhibition of Vascular Endothelial Growth Factor Expression in HEC1A Endometrial Cancer Cells through Interactions of Estrogen Receptor alpha and Sp3 Proteins J. Biol. Chem., July 21, 2000; 275(30): 22769 - 22779. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |